Search Results - Dirk Schadendorf

Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. by Dagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, Dirk Schadendorf, Katharina C Kähler, Christian Hafner, Nora Kramer, Waltraud Fröhlich, Reinhard Dummer, Carola Berking, Stefan Schliep, Michael C Kirchberger, Lucie Heinzerling

Get full text

RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melan... by Sara Egea‐Rodriguez, Renáta Váraljai, Thierry M. Nordmann, Restuan Lubis, Manuel Philip, Florian Rambow, Alexander Roesch, Michael Flaig, Susanne Horn, Raphael Stoll, Fang Zhao, Annette Paschen, Bert Klebl, Ian D. Hickson, Dirk Schadendorf, Matthias Mann, Iris Helfrich

Get full text

Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance by Antonia Kolb, Ana-Marija Kulis-Mandic, Matthias Klein, Anna Stastny, Maximilian Haist, Vanessa Votteler, Beate Weidenthaler-Barth, Tobias Sinnberg, Antje Sucker, Gabriele Allies, Lea Jessica Albrecht, Alpaslan Tasdogan, Andrea Tuettenberg, Matthias M. Gaida, Carsten Deppermann, Henner Stege, Dirk Schadendorf, Stephan Grabbe, Klaus Schulze-Osthoff, Daniela Kramer

Get full text